8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Boston Scientific ($BSX) and Penumbra ($PEN) on Jan 15, 2026 executed a definitive agreement for BSX to…
Filed with the SEC on · Summarized by InvestorsBot
Boston Scientific ($BSX) and Penumbra ($PEN) on Jan 15, 2026 executed a definitive agreement for BSX to acquire Penumbra; Pinehurst Merger Sub, Inc. is BSX’s merger subsidiary. Conference call + investor presentation posted. Transaction subject to regulatory/closing conditions. 🏥 #M&A #MedTech
BSX will file a Form S‑4 with a Proxy Statement/Prospectus; Penumbra will mail it to its shareholders. Press Release & Investor Presentation attached as Exhibits 99.1/99.2 to the 8‑K. Filing warns of forward‑looking risks; closing is not guaranteed. 📄 $BSX $PEN #SECfiling #DueDiligence